Arlene H. Sharpe

Immunology · 2000–2021

A researcher in the Science corpus: 32 papers; trusts 21 researchers and is trusted by 37 researchers here, as inferred from the citation graph.

Subfields

Whom Arlene H. Sharpe trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. Taku Okazaki
  2. G. Freeman
  3. Lieping Chen
  4. E. Wherry
  5. Daniel L. Barber
  6. James L. Riley
  7. R. Parry
  8. D. Pardoll
  9. Kristen E. Pauken
  10. M. Butte

Who trusts Arlene H. Sharpe overall

  1. E. Wherry
  2. James L. Riley
  3. Herbert W. Virgin
  4. Daniel L. Barber
  5. Loise M. Francisco
  6. G. Dranoff
  7. Lieping Chen
  8. B. Fife
  9. Rafi Ahmed
  10. D. Pardoll

Papers from Arlene H. Sharpe's perspective

Ordered by how strongly the researchers Arlene H. Sharpe trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice. (Science)
  2. Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade (Proceedings of the National Academy of Sciences of the United States of America)
  3. SHP-1 and SHP-2 Associate with Immunoreceptor Tyrosine-Based Switch Motif of Programmed Death 1 upon Primary Human T Cell Stimulation, but Only Receptor Ligation Prevents T Cell Activation1 (Journal of Immunology)
  4. Restoring function in exhausted CD8 T cells during chronic viral infection (Nature)
  5. Blockade of B7-H1 improves myeloid dendritic cell–mediated antitumor immunity (Nature Medicine)
  6. Programmed death-1 ligand 1 interacts specifically with the B7-1 costimulatory molecule to inhibit T cell responses. (Immunity)
  7. The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection (Nature Immunology)
  8. Regulatory T cell lineage specification by the forkhead transcription factor foxp3. (Immunity)
  9. Loss of tumor suppressor PTEN function increases B7-H1 expression and immunoresistance in glioma (Nature Medicine)
  10. Blockade of B7-H1 and PD-1 by monoclonal antibodies potentiates cancer therapeutic immunity. (Cancer Research)

Their papers